Research Archive — Page 54 of 134
-
August 11, 2022
Genotype-specific blood counts
Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts. -
August 11, 2022
Cell-free breast cancer “biopsy”
The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer. -
August 5, 2022
Study that investigated whether three smoking cessation drugs could reduce alcohol intake yields unexpected finding
A Vanderbilt study of three proven smoking cessation treatments suggests these medications could play an important role to reduce alcohol use and smoking at the same time. -
August 4, 2022
Study tracks limited use of influenza antiviral therapy
A Vanderbilt study found that more than half of children diagnosed with influenza and deemed high risk for flu-related complications were given the recommended antiviral treatment. -
August 2, 2022
Targeted cancer drug during pregnancy
The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians. -
August 1, 2022
H. pylori and lung cancer
Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered. -
July 28, 2022
Video vital for telehealth visits
Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.